Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Medipharm Labs Corp (MEDIF)

Medipharm Labs Corp (MEDIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA GlobeNewswire - 1 hour ago

Q1 2026 Positive Adjusted EBITDA (1) Net Revenue of $9M with strong gross margins of 37% OPEX decreased 28% in Q1 2026 versus Q4 2025 Company is virtually debt free, with a Q1 ending cash balance of...

MEDIF : 0.0628 (-1.10%)
LABS.TO : 0.0800 (-5.88%)
MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results GlobeNewswire - Thu May 7, 7:05PM CDT

TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp.  (TSX:  LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based...

MEDIF : 0.0628 (-1.10%)
LABS.TO : 0.0800 (-5.88%)
MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling GlobeNewswire - Mon Apr 27, 7:30AM CDT

On April 22, 2026, the U.S. Department of Justice and Drug Enforcement Administration’s final order rescheduling FDA-approved cannabis drug products and state-licensed medical cannabis from Schedule...

MEDIF : 0.0628 (-1.10%)
LABS.TO : 0.0800 (-5.88%)
MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue GlobeNewswire - Mon Mar 30, 6:45AM CDT

FY 2025 revenue of $45.1 million, an increase of 8% over 2024 International Medical Cannabis revenue increased 43% year-over-year and represented more than 50% of total revenue Increased cash balance...

MEDIF : 0.0628 (-1.10%)
LABS.TO : 0.0800 (-5.88%)
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results GlobeNewswire - Wed Mar 25, 6:05PM CDT

TORONTO, March 25, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp.  (TSX:  LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0628 (-1.10%)
LABS.TO : 0.0800 (-5.88%)
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results GlobeNewswire - Wed Mar 25, 6:05PM CDT

TORONTO, March 25, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp.  (TSX:  LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0628 (-1.10%)
LABS.TO : 0.0800 (-5.88%)
MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO GlobeNewswire - Mon Jan 19, 7:00AM CST

TORONTO, Jan. 19, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids,...

MEDIF : 0.0628 (-1.10%)
LABS.TO : 0.0800 (-5.88%)
MediPharm Labs to Enter New Market with Costa Rica Supply Agreement GlobeNewswire - Tue Jan 13, 7:00AM CST

TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specialized...

MEDIF : 0.0628 (-1.10%)
LABS.TO : 0.0800 (-5.88%)
Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience GlobeNewswire - Fri Dec 19, 2025

TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based...

MEDIF : 0.0628 (-1.10%)
LABS.TO : 0.0800 (-5.88%)
MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns GlobeNewswire - Wed Dec 10, 2025

TORONTO, Dec. 10, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids,...

MEDIF : 0.0628 (-1.10%)
LABS.TO : 0.0800 (-5.88%)

Barchart Exclusives

Intel Stock Just Got a New Street-High Price Target. Wall Street Is Starting to Believe Its Foundry Can Work. Barchart - 9 minutes ago
A potential Apple partnership and a new street-high price target are fueling fresh optimism that Intel’s foundry ambitions may finally be paying off. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.